PDCI Blog

12

Sep2017
Canada’s “health leaders” sponsoring the Open Pharma campaign should have checked with the Patented Medicine Prices Review Board (PMPRB) before advocating their ill-conceived and impractical proposal to have the federal government amend the Patented Medicines Regulations to force drug manufacturers to disclose payments to physicians via the PMPRB. An ... Read More

28

Jul2017
The release of the Patented Medicine Prices Review Board (PMPRB) Annual Report is delayed once again this year - so much for transparency and the PMPRB’s mission statement to “provide stakeholders with price, cost, and utilization information to help them make timely and knowledgeable drug pricing, purchasing, and reimbursement ... Read More